Arvinas (ARVN) Other Working Capital Changes (2017 - 2026)
Arvinas (ARVN) recorded quarterly Other Working Capital Changes of -$15.6 million in Q1 2026, down 64.21% quarter-over-quarter from -$9.5 million in Q4 2025, and down 677.78% on a YoY basis from $2.7 million in Q1 2025.
Arvinas (ARVN) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Arvinas' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at -$15.6 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 677.78% year-over-year to -$15.6 million; the TTM figure through Mar 2026 stood at -$260.9 million (down 23618.18% YoY), while the FY2025 annual figure was -$242.6 million, down 12668.42% from the prior year.
- Other Working Capital Changes was -$15.6 million for Q1 2026 at Arvinas, down from -$9.5 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $70.8 million in Q3 2023 to a low of -$214.0 million in Q2 2025.
- Historically, Other Working Capital Changes has averaged -$15.3 million across 5 years, with a median of -$8.3 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes sank 1109.52% in 2022, then surged 5250.0% in 2023.
- A 5-year view of Other Working Capital Changes shows it stood at -$200000.0 in 2022, then soared by 5250.0% to $10.3 million in 2023, then plunged by 180.58% to -$8.3 million in 2024, then slipped by 14.46% to -$9.5 million in 2025, then tumbled by 64.21% to -$15.6 million in 2026.
- The last three Other Working Capital Changes figures came in at -$15.6 million (Q1 2026), -$9.5 million (Q4 2025), and -$21.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.60 Mn |
| Mar 31, 2026 | -15.60 Mn |
| Dec 31, 2025 | -9.50 Mn |
| Dec 31, 2025 | -9.50 Mn |
| Sep 30, 2025 | -21.80 Mn |
| Sep 30, 2025 | -21.80 Mn |
| Jun 30, 2025 | -214.00 Mn |
| Jun 30, 2025 | -214.00 Mn |
| Mar 31, 2025 | 2.70 Mn |
| Mar 31, 2025 | 2.70 Mn |
| Dec 31, 2024 | -8.30 Mn |
| Dec 31, 2024 | -8.30 Mn |
| Sep 30, 2024 | -43.60 Mn |
| Sep 30, 2024 | -43.60 Mn |
| Jun 30, 2024 | 48.10 Mn |
| Jun 30, 2024 | 48.10 Mn |
| Mar 31, 2024 | 1.90 Mn |
| Mar 31, 2024 | 1.90 Mn |
| Dec 31, 2023 | 10.30 Mn |
| Dec 31, 2023 | 10.30 Mn |